153 results
Page 3 of 8
PX14A6G
fn8ip
7 Apr 20
Letter to shareholders
9:08am
8-K
EX-99.1
1h4el
7 Feb 20
AbbVie Reports Full-Year and Fourth-Quarter 2019 Financial Results
7:48am
8-K
EX-99.1
4tocejvq
13 Nov 19
AbbVie Prices $30 Billion of Senior Unsecured Notes
4:43pm
8-K
EX-99.2
xh6y56z9k7m q1kmz
6 Nov 19
Regulation FD Disclosure
3:30pm
8-K
EX-99.1
432om4
1 Nov 19
AbbVie Reports Third-Quarter 2019 Financial Results
7:50am
424B5
flhx p9aam49s
19 Sep 19
Prospectus supplement for primary offering
5:18pm
424B3
kkeob g2lxh
16 Sep 19
Prospectus supplement
6:14am
8-K
EX-99.1
x09oaz y0
16 Sep 19
Index to Consolidated Financial Statements
6:08am
8-K
EX-99.1
jdhs2v3j
26 Jul 19
AbbVie Reports Second-Quarter 2019 Financial Results
7:44am
8-K
EX-99.1
8t8bvesk
25 Jun 19
This Announcement Is Being Made Pursuant to Rule 2.5 of the Irish Takeover Rules
5:26pm
8-K
EX-99
iq4gi4j
25 Apr 19
AbbVie Reports First-Quarter 2019 Financial Results
7:45am